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Abstract An in silico survey of the 31 subsite of all known
3D-structures of O-glycoside hydrolases containing a suitably
positioned ligand has led to the recognition ^ apparently without
exceptions ^ of a transition state stabilising hydrophobic plat-
form which is complementary to a crucial hydrophobic patch of
the ligand. This platform is family-speci¢c and highly conserved.
A comprehensive list is given with examples of enzymes belong-
ing to 33 di¡erent families. Several typical constellations of
platform ^ protein residues are described.
$ 2003 Published by Elsevier Science B.V. on behalf of the
Federation of European Biochemical Societies.
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1. Introduction
O-Glycoside hydrolases (EC 3.2.1.x) are abundantly present
in nature. On the basis of amino acid sequence similarity, this
structurally variable group of enzymes has hitherto been clas-
si¢ed into 85 di¡erent families [1,2], and observation of fold
conservation allowed some families to be grouped in clans [3].
Although the 3D-structures of hundreds of O-glycoside hy-
drolases have already been solved, data are still missing for
representatives of more than 40 families. Of prime importance
for insight into ligand recognition, substrate speci¢city and
modus operandi, is the availability of structural data of en-
zymes containing a ligand within the active centre, especially
in the crucial 31 subsite since there the carbohydrate’s con-
formation and con¢guration change during the hydrolysis re-
action. For enzymes in more than 30 O-glycoside hydrolase
families, this has been addressed by the use of speci¢c inhib-
itors, cryo-techniques, or site-directed mutagenesis. A major
breakthrough is the development of 2-deoxy-2-£uoro-deriva-
tives, allowing the covalent trapping of the glycosyl-enzyme
intermediate of many retaining hydrolases [4].
With almost no exceptions, O-glycoside hydrolases possess
at their active centre two mechanistically important carboxyl
functions at the subsites’ 31/+1 junction [5] : (i) a syn or anti
positioned [6] proton donor close to the oxygen atom of the
scissile glycosidic bond; and (ii) a nucleophilic carboxylate
residue (retaining hydrolases) or a solvent-nucleophile assist-
ing carboxylate residue (inverting hydrolases). For several de-
cades there have been major controversies in the literature
concerning the mechanistic details of a glycoside hydrolysis,
more speci¢cally, to what extent stereoelectronic e¡ects are
operative; these apparently have ended with a highly author-
ative article by P. Deslongchamps [7]. The nucleophilic dis-
placement reaction is borderline SN2^SN1, in which C1 and
O5 at the stage of the transition state have an sp2-hybridised
geometry with considerable mutual double bond character.
The current understanding of glycosidase mechanisms has re-
cently been thoroughly reviewed [8].
2. Hydrophobic platforms in the 31 subsite of glycoside
hydrolases
A pre-arranged complementarity [9] which speci¢cally sta-
bilises the transition state [10] is important in enzyme cata-
lysed reactions. Fig. 1 (top left) shows a D-hexapyranoside in
a ground state 4C1 chair conformation, with the C5-hydroxy-
methylene functionality occupying an equatorial position.
Corresponding transition states should have C2, C1, O5 and
C5 residing within the same plane allowing orbital overlap
between a ring-oxygen’s lone pair and the scissile bond, as
is the case for a 4H3 half-chair, an E3 envelope and a 2;5B
boat conformation (respectively Fig. 1 top right, bottom left
and bottom right). In this order, these three conformations
are neighbours within the pseudorotational sequence of a
double bond-containing six-membered ring. Note that the
next pseudorotational neighbour, an E4 envelope, is unlikely
as a transition state candidate because of an unfavourable C3
hydroxyl^C5 hydroxymethylene syn-diaxial position. Also, a
rigorous 2;5B boat transition state conformation is unlikely
because it contains an eclipsed C3^C4 bond and an unfavour-
able 2,5-£agpole steric interaction. This however can be re-
lieved by a small twist in the direction of a neighbour in the
pseudorotational sequence.
It is clear from Fig. 1 that in these putative transition states
the C4^C5^C6 hydrophobic patch at the B-face [11] has sub-
stantially tilted out of the equatorial plane, relative to the
situation in the ground state. As a sialic acid glycosidic ring
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shows a ground state 2C5 conformation (corresponding to 1C4
for penta/hexapyranosides), K-sialidases will probably hydro-
lyse their substrate through a 4H3 transition state conforma-
tion (corresponding to 3H4 for penta/hexapyranosides) [12^
14]; its hydrophobic patch now however resides at the ring-
C3-methylene group (see further). Family 11 xylanases have
been suggested to operate through a 2;5B conformation
[15,16]. The same has been proposed for family 6 Trichoderma
reesei cellobiohydrolase II (Cel6A) [17] and the occurrence of
a B2;5 transition state has been suggested for family 26
L-mannanases [18]. Both hexapyranoside boat conformations
however would also present an unfavourable C5 hydroxy-
methylene, respectively C3 hydroxyl, syn-diaxial interaction
versus the leaving group at C1 ; the pseudorotational neigh-
bour without this interaction is respectively an E3 and an 4E
envelope. K(1,2)-Mannosidases from families 38 and 47 prob-
ably operate through a 3H4 transition state conformation [19^
22] (see further). However, in all these instances a similar tilt
of the corresponding hydrophobic patch occurs.
This raises an obvious question: are all O-glycoside hydro-
lases equipped with one or more hydrophobic amino acid
residues within the 31 subsite so as to be complementary to
the carbohydrate’s out-of-plane hydrophobic patch at the
stage of the transition state (and not or much less so with
the hydrophobic patch in the ground state chair situation)?
Since van der Waals’ contributions to protein/ligand interac-
tions can be quite large, this question is of relevance. Indeed,
for interactions between ligand/enzyme lipophilic surfaces, the
free energy contribution is estimated to be 30.1 [23] to 30.2
kJ mol31 AO 32 [24,25]. Recent experimental evidence even sug-
gests a value of 30.5 kJ mol31 AO 32 [26].
An in silico survey of the 31 subsites of all as yet known
3D-structures of ligand/enzyme cocrystallysates and/or
trapped O-glycosyl-enzyme intermediates leads to the follow-
ing observations. Independently of being retaining or invert-
ing, or K or L O-pyranoside-glycoside hydrolases, all available
structures possess within subsite 31, at approximately the
same position i.e. at the B-face and close to the C5-hydroxy-
methylene function of the ligand-carbohydrate moiety, a fam-
ily-speci¢c hydrophobic platform consisting of one (or two)
aromatic amino acid residue(s) (Figs. 1 and 2). Only three
variations occur with a non-aromatic platform: (i) the family
11 xylanases where, opposite to the xylopyranoside’s ring-C5-
methylene function, a non-aromatic hydrophobic protein res-
idue is found; (ii) the family 14 (gluco)amylases containing a
discrete non-aromatic hydrophobic system; and (iii) the clan-
E sialidases where the ring-C3-methylene function of the neu-
raminic acid analogous ligand also has a non-aromatic hydro-
phobic protein residue in juxtaposition (see further). Subse-
quent checking with the PFAM sequence-alignment server
[27] shows that these residues are highly conserved within
each family. Table 1 presents a selection of representatives
of 33 di¡erent hydrolase families, the relevant PDB ¢les and
the nature of the respective hydrophobic platforms. Fig. 2
shows a typical situation in many L(1,4)-glucoside hydrolases.
Although this survey cannot be exhaustive, the presently
available 3D-data show no exceptions. When more than one
structure with a suitably situated ligand has been published
for the same enzyme, the entry with the covalent glycosyl-
enzyme intermediate (if available) was preferred for inclusion
in Table 1.
It must be emphasised that, in X-ray derived structures, all
carbohydrate ligands reside in a ground state chair or in a
(skew-)boat conformation which is necessarily a local energy
minimum, since it is unlikely that enzymes are capable to
impose a catalytically signi¢cant strain upon their substrate
[28]. In several cases (e.g. [15, 18, 29^31]) a (skew-)boat con-
formation is observed for the carbohydrate moiety in subsite
31, and the energetic penalty must have been paid for by a
number of compensating protein^ligand interactions. Such a
conformation belongs to the mechanistic itinerary of a glyco-
side hydrolysis, i.e. the interconversion of a L-chair glycoside
^ protonated L-(skew-)boat ^ transition state ^ protonated
K-chair ^ protonated K-(skew-)boat ^ K-chair glycoside (or
vice versa) [7]. Apart from mechanistic implications [8], an
observed (skew-)boat can resemble the transition state more
than a chair conformation, and therefore might ¢t better in
the 31 subsite. It nevertheless still has to be a local minimum
^ in casu the conformation with the lowest energy when the
ligand is surrounded by the enzyme’s active centre residues
(and not by the solvent). However, an experimentally ob-
Fig. 1. A L-hexapyranoside in a ground state 4C1 chair (top left),
and transition state 4H3 half-chair (top right), E3 envelope (bottom
left) and 2;5B boat (bottom right) conformations. Shown with a phe-
nylalanine protein residue as a hydrophobic platform at the carbo-
hydrate’s B-face close to the C5-hydroxymethylene group. L=Leav-
ing group; Nu=nucleophile.
Fig. 2. A typical position of an aromatic hydrophobic platform at
the B-face and close to C5^C6 of a L-D-hexapyranoside ligand with-
in subsite 31. This situation is observed in many L(1,4)-glycoside
hydrolases. R=H or glycopyranosyl, RP=OH or N-acetyl.
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served ligand-conformation will be energetically far away
from the short-lived high-energy transition state. Therefore,
the shortest ligand^protein residue distances in Table 1 can
substantially di¡er from these occurring with the real transi-
tion state.
3. Description of the platforms in several families and clans
The amino acid residues that give rise to the hydrophobic
platforms are speci¢c for each glycoside hydrolase family and
are partly conserved within clans. The situation can however
be quite di¡erent for non-clan related families and necessitates
separate descriptions.
3.1. Clan-A
Clan-A comprises 16 di¡erent families that share a common
(L/K)8 fold and act by a retaining mechanism on various
L(1,4)-glycosides. Structures with a suitably positioned ligand
are available for members of six families (see Table 1). These
enzymes show a ‘platform-triad’ constellation of protein res-
idues at the B-face near C5 of the ligand in subsite 31 (Fig.
3): (i) ‘left’, a highly conserved tryptophan close to the C4^C5
hydrophobic patch; (ii) ‘top’, a not-always-present aromatic
residue close to C6 ; and (iii) ‘right’, a conserved tyrosine with
its hydroxyl function pointing towards the O5 ring oxygen
(but probably less involved in a hydrophobic interaction). A
typical example of the full platform-triad is the left Trp313 /
Table 1
List of enzyme structures and their hydrophobic platform
Family Organism Enzyme (mechanism)a PDBh Platform Ligand Shortest distance (AO )
1/A B. polymyxa 1,4-L-glucosidase (r) 1e4i W398/F414(/Y296) GluF-glycenz. 3.86(C5-WCD1)/3.68(C6-FCZ)
1/A S. alba myrosinase (r) 1e73 W457/F473(/Y330) GluF-glycenz. 3.52(C5-WCE2)/3.56(C6-FCZ)
2/A E. coli L-galactosidase (r) 1jz0 W568(/Y503) GalF-glycenz. 3.32(C5-WCE2)
3 H. vulgare 1,4-L-glucohydrolase (r) 1iew F144/L54/M316 GluF-glycenz. 3.95(C6-FCD2)/4.09(C6-LCD1)/3.36(C6-MCE)
5-1/A A. cellulolyticus 1,4-L-endoglucanase (r) 1ece W319/T328(/Y240) cellotetraose 4.36(C4-WCE2)/3.99(C6-TCG2)
5-2/A B. agaradhaerens 1,4-L-endoglucanase (r) 1h2j W262(/Y202) GluF-glycenz. 3.88(C5-WCD1)
5-3/A C. thermocellum 1,4-L-glucohydrol.b (r) 1cen W313/F320(/Y200) cellohexaose 3.40(C5-WCD1)/3.64(C6-FCE1)
6 T. reesei 1,4-L-exoglucanase (i) 1qk0 Y169 GX-IBni 4.05(C5-YCZ)
7/B F. oxysporum 1,4-L-endoglucanase (r) 1ovw Y145 thio-G5j 3.49(C6-YCE1)
8/M C. thermocellum 1,4-L-exoglucanasec (i) 1kwf W132 cellohexaose 3.55(C6-WCZ3)
9 T. fusca 1,4-L-endoglucanase (i) 4tf4 Y429/A426 cellopentaose 4.45(C6-YCZ)/4.56(C6-ACB)
10/A C. ¢mi xylanase (r) 2xylh W273/W281(/H205) X2F-glycenz. 3.87(C5-W273CE2)/3.89(C5-W281CZ3)
11/C B. circulans xylanase (r) 1bvv V37 X2F-glycenz. 3.72(C5-VCG2)
12/C S. lividans 1,4-L-glucanase (r) 2nlr Y57 G3F-glycenz. 3.58(C6-YCB)
13/H H. vulgare 1,4-K-glucanase (r) 1bg9 F143 acarbose (-1/+3) 3.55(C6-FCE1)
14 B. cereus 1,4-L-glucoamylase (i) 1b9z A170/K287/E172 maltose 4.86(C6-ACB)/4.08(C6-KCD)/4.22(C6-ECG)
14 soybean 1,4-L-amylase (i) 1byd A184/K295/E186 2-deoxymaltose 4.54(C6-ACB)/4.05(C6-KCD)/4.54(C6-ECG)
15/L A. awamori 1,4-K-glucoamylase (i) 1gai W52 G-H2-acarbosek 3.56(C6-WCD2)
16/B B. macerans lichenase (r) 1byh F92l epoxybutyl-G2l not measurablel
18/K S. marcescens chitinased (r) 1¡r W539 (NAG)6 3.72(C5-WCD2)
20/K S. marcescens chitobiasee (r) 1c7s W737/Y669 chitobiose 3.81(C5-WCG)/4.11(C5-YCE2)
22 G. gallus lysozyme (r) 1h6m W108 (Chit)2F-glycenz. 3.98(C6-WCD1)
23 C. atratus lysozyme (i) 1lsp Y147 bulgecin A 3.65(C5-YCE2)
24/I BacteriophageT4 lysozymef (i) 148l F104 glycenz. 3.60(C6-FCD1)
26/A C. japonicus L-mannanase (r) 1gw1 W360/W379(/Y285) (M)3F-glycenz. 3.69(C5-W360CD1)/3.47(C6-W379CH2)
27/D G. gallus K-galactosaminidase (r) 1ktc W16 NAGal 3.50(C6-WCZ2)
33/E B. typhimurium K-sialidase (r) 2sim at C3 : Y342/I38 DD-neuram.m 3.76(C3-YCZ)/3.87(C3-ICD1)
34/E In£uenza virus K-sialidase (r) 2bat at C3 : Y406/E119 sialic acid 3.95(C3-YCZ)/4.79(C3-ECG)
38 D. melanogaster 1,2-K-mannosidase (r) 1hxk W95/Y727 deoxymannojir. 3.62(C5-WCZ2)/3.88(C6-YCZ)
42/A T. thermophilus L-galactosidase (r) 1kwk F350(/H363/Y266) galactose 3.65(C4-FCZ)
45 H. insolens 1,4-L-endogluc.g (i) 4eng Y8n 2U cellotriosen not measurablen
47 H. sapiens 1,2-K-mannosidase (i) 1fo3 F659 kifunensine 3.59(C5-FCD2)
48/M C. cellulolyticum cellulase (i) 1f9d W154 2U cellotetraose 3.30(C5-WCD2)
56 A. mellifera hyaluronidase (r) 1fcv W301/W267 (hyaluron.)4 3.85(C5-W301CZ3)/4.01(C6-W267CZ3)
67 C. japonicus K-glucuronidase (i) 1gql F327 glucuronic acid 3.65(C5-FCE2)
77/H T. aquaticus amylomaltase (r) 1esw W258 acarbose (33/+1) 4.85(C6-WCG)
83/E Paramyxovirus K-sialidase (r) 1e8v at C3 : Y526/I175 DD-neuram.m 3.92(C3-YCZ)/4.07(C3-ICD1)
ar = retaining; i = inverting.
bG140Q mutant.
cE95Q mutant.
dY390F mutant.
eD539A mutant.
fT26E/C54T/C97A mutant.
gD10N mutant.
hReference in PDB-¢le 2xyl incorrect, see [39]; all other references as in the respective PDB-¢le.
im-Iodobenzyl L-D-glucopyranosyl-L(1C4)-D-xylopyranoside.
jMethyl S-L-D-glucopyranosyl-(1C4)-S-4-thio-L-D-glucopyranosyl-(1C4)-S-4-thio-L-D-glucopyranosyl-(1C4)-S-4-thio-L-D-glucopyranosyl-(1C4)-
4-thio-K-D-glucopyranoside.
kD-Gluco-dehydroacarbose.
lEpoxybutyl-trapped glycosyl-enzyme intermediate. Phe92 pinpointed from relative positions of subsite 31 residues.
m2,3-Dehydro-2-deoxy-N-acetyl neuraminic acid.
nSubsite 31 empty. Tyr8 pinpointed by comparing the subsite 31 residues with the ligand-positions in the adjacent subsites.
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top Phe320 / right Tyr200 combination in the L(1,4)-glucoside
hydrolase Cel5B from Clostridium thermocellum (PDB 1cen)
belonging to family 5, subfamily 3 [32], as shown in Fig. 3.
The same triad is present in the family 1 Sinapis alba myro-
sinase (PDB 1e73) catalysing a thioglycosidic bond hydrolysis
and using ascorbate as cofactor [33].
The ‘top’ residue of the platform-triad varies considerably
throughout clan-A, but less so within its families. In family 1,
this is phenylalanine or (less frequently) a tryptophan. In the
family 2 Escherichia coli L-galactosidase example however
(PDB 1jz0), a highly organised and conserved Naþ binding
network is situated at the ‘top’ position, interacting with the
C6-hydroxyl group of the 2-deoxy-2-£uoro-D-galactosyl-en-
zyme ligand [34]. This family is the only one containing
L-glucuronidases, and the metal-ion sca¡old is probably na-
ture’s solution for an antipole towards the C6-carboxyl group
of a glucuronide. Unfortunately, no 3D-structure of a family
2 glucuronidase with a substrate derivative occupying subsite
31 is available. In families 10 and 26, ‘top’ is a conserved
tryptophan. An interesting variation appears in family 42,
where ‘left’ and ‘top’ respectively consist of conserved phenyl-
alanine and histidine residues.
Within the family 5 enzymes considerable variation in the
‘top’ residue occurs. Sequence alignment comparison often
shows Phe, Trp, Thr and Val residues; but also Gly, Ala
and even Glu can be present. The substrate speci¢city of
this family is quite broad and some members share compara-
tively closer sequence identity, which has lead to a subdivision
into as yet six subfamilies [35^37]. For three of these, struc-
tures with a suitable ligand in subsite 31 are available (Table
1). The family 5-1 example has the methyl group of a threo-
nine on ‘top’; in 5-2 ‘top’ is absent, while the 5-3 example
(Fig. 3) exhibits the more common ‘top’-phenylalanine.
3.2. Clan-B
In their recent study of the Pseudoalteromonas carrageeno-
vora U-carrageenase structure and its comparison with other
clan-B L-retaining glycoside hydrolases (families 7 and 16), G.
Michel and coworkers have observed that, in spite of their
wide substrate diversity, all clan-B members feature one aro-
matic amino acid residue at exactly the position indicated in
Fig. 2. They suggest its presence to be ‘‘for the correct posi-
tioning of the glycoside unit undergoing the nucleophilic sub-
stitution’’. Sequence comparison even indicates that the type
of residue is substrate-speci¢c: tryptophan in U-carrageenases,
L-agarases and 1,3-L-glycanases; tyrosine in xyloglucan endo-
transglycosylases and the family 7 cellulases; and phenylala-
nine in 1,3^1,4-L-glucan hydrolases (lichenases) [38].
3.3. Family 10 and 11 xylanases
Although their natural substrate lacks C5-hydroxymethy-
lene groups, an analogous hydrophobic platform is also found
within the xylan-degrading enzymes of family 10 and 11. At
the B-face of pentapyranosides, a ring-C5-methylene hydro-
phobic patch is still present; and again, at the transition state
this patch may be recognised by a complementary platform
better than it is at the 4C1 chair ground state.
Family 10 xylanases are equipped with a rigorously con-
served variant of the clan-A platform-triad in which the ‘right’
protein residue is now a histidine while the ‘left’ and ‘top’
tryptophans appear to be sandwiching the ring-C5-methylene
function of the D-xylopyranosyl moiety. A typical example is
the Trp273/Trp281/His205 constellation with the 2-deoxy-2-
£uoro-xylobiosyl-enzyme intermediate of the Cellulomomas
¢mi xylanase Xyn10A (CEX; PDB 2xyl) [39], as shown in
Fig. 4.
Family 11 xylanases, belonging to clan-C, show a single
valine, leucine or isoleucine in juxtaposition to the ligand’s
ring-C5-methylene group; e.g. Val37 near the 2-deoxy-2-£uo-
ro-xylobiosyl-enzyme intermediate (with the xylopyranosyl
ring at subsite 31 in a 2;5B conformation) of the Bacillus
circulans xylanase example (PDB 1bvv) [15] (Table 1). This
clan also comprises family 12 glucoside hydrolases, where the
Streptomyces lividans 2-deoxy-2-£uoro-cellotriosyl-enzyme in-
termediate example (PDB 2nlr) [40] shows the usual aromatic
residue (Fig. 2), in casu a family-conserved tyrosine, as hydro-
phobic platform.
3.4. Family 14
Structures containing a ligand within subsite 31 have been
published for two members of this family of L-inverting (glu-
co)amylases (see Table 1) [41,42]. Both reveal an identical
system of three highly conserved non-aromatic amino acid
residues at the B-face of the ligand, in a similar position as
in the above described platform-triad within clan-A: (i) ‘left’,
an alanine with its methyl group pointing towards C6 ; (ii)
‘top’, a lysine with its penultimate methylene close to C6
(and its amino group hydrogen-bonding to the C6-hydroxyl
Fig. 3. A typical clan-A Trp/Phe/Tyr platform-triad in the family
5-3 C. thermocellum Cel5B L(1,4)-glucanase. R=D-glucopyranosyl.
Fig. 4. A typical family 10 clan-A platform-triad variant with a
‘right’ histidine and with the ligand’s ring-C5-methylene function
sandwiched between the ‘left’ and ‘top’ tryptophan residues. Shown
is the situation with the 2-deoxy-2-£uoro-xylobiosyl-enzyme inter-
mediate of the C. ¢mi xylanase Xyn10A. R=L-D-xylopyranosyl.
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group); and (iii) ‘right’, a glutamate with its K-methylene near
C6. The situation in the Bacillus cereus var. myciodes gluco-
amylase (PDB 1b9z) [41] is shown in Fig. 5.
3.5. The family 26 mannanases, and family 38 and 47
mannosidases
Although the ground state conformation of a mannopyra-
noside ring is a 4C1, molecular orbital calculations have
shown that a mannopyranosyl cation prefers a 3H4-like geom-
etry over a 4H3 [19]. This suggests that dedicated mannosyl
hydrolase families might have evolved to hydrolyse their sub-
strate through a 3H4, 3E or B2;5 transition state.
The family 26 retaining endo-L(1,4)-mannanase A
(Man26A) from Clypeaster japonicus (formerly Pseudomonas
cellulosa) belongs to clan-A, its 3D-structure (e.g. PDB 1gw1)
[18,43] showing in subsite 31 a clan-A hydrophobic platform-
triad variant with left Trp360 / top Trp379 / right Tyr285.
Very intriguing for this family is that it also contains L(1,3)-
xylanases; indeed, the double left/top tryptophan also occurs
as a conserved clan-A platform-variant with the family 10/
clan-A L(1,4)-xylanases. Complexes of the Man26A catalytic
acid/base E212A mutant with the mechanism-based substrate
2,4-dinitrophenyl 2-deoxy-2-£uoro-L-mannotrioside revealed
at the Michaelis complex a 1S5 skew-boat for the mannopy-
ranoside ring at subsite 31 while the glycosylenzyme inter-
mediate shows a OS2 skew-boat. This has lead to the sugges-
tion that a B2;5 would occur at the transition state [18], not
withstanding several unfavourable steric interactions as dis-
cussed above.
The family 38 retaining Drosophila Golgi K-mannosidase II
structures in complex with 1- deoxymannojirimycin (PDB
1hxk) and swainsonine (PDB 1hww) [20] show these inhibitors
at their B-site stacking to Trp95 while a nearby Tyr727 is in a
position similar to the clan-A ‘right’ triad residue; their C2
and C3 hydroxyl groups coordinate with an essential zinc ion.
The strong inhibitor capacity of swainsonine (IC50 20 nM)
[20] and its neat superimposition on a 3H4 mannopyranosyl
cation structure [19] indicates a hydrolysis mechanism passing
through a 3H4 transition state conformation.
Of two members of the family 47 inverting K(1,2)-manno-
sidases, 3D-structures with 1-deoxymannojirimycin and kifu-
nensine occupying subsite 31 have been published. Both the
Homo sapiens [21] and the Penicillium citrinum [22] enzymes
show only one hydrophobic protein residue in the 31 subsite,
i.e. a conserved phenyl alanine (respectively Phe659 and
Phe468), which is at van der Waals distance with C4, C5
and C6 of the inhibitor; the C2 and C3 hydroxyl groups of
the inhibitor coordinate with an essential calcium ion. In all
cases, the inhibitor was found to reside in a non-standard 1C4
conformation, in which the C4^C5^C6 hydrophobic patch at
the B-face is fully exposed to the adjacent phenyl alanine plat-
form. This C3^C4^C5 ‘all-axial’ substituent positioning also
suggests the hydrolysis mechanism to pass through a geomet-
rically related 3H4 or 3E transition state conformation. The
situation with the H. sapiens K(1,2)-mannosidase I in complex
with kifunensine (PDB 1fo3) is shown in Fig. 6.
3.6. Clan-E
Acetylneuraminyl hydrolases (exo-K-sialidases, E.C.
3.2.1.18) are exclusively found in clan-E which contains the
families 33, 34 and 83. A C6-trihydroxypropyl group is
present in their substrate, and the sialidases expectedly exhibit
a complementary polar and hydrogen bonding network at its
surroundings within subsite 31. However, the sialic acid moi-
ety also has a ring-C3-methylene function (this position cor-
responds to C2 for pentapyranosides), and, going from the
ground state 2C5 chair conformation (corresponding to 1C4
for pentapyranosides) to the transition state, this group
undergoes about the same reorientation as the ring-C5-meth-
ylene of a xylopyranoside substrate. It comes then as almost
no surprise that a non-aromatic hydrophobic protein residue
is juxtaposed to the ring-C3-methylene group within enzymes
Fig. 5. The family 14 hydrophobic Ala/Lys/Glu platform-triad in
B. cereus glucoamylase. The methylene groups close to C6 of the
ligand are indicated with an asterisk. R=K-D-glucopyranosyl.
Fig. 6. The family 47 single Phe platform in H. sapiens K(1,2)-man-
nosidase I complexed with kifunensine.
Fig. 7. A Clan-E Ile/Tyr protein residue platform-diad in juxtaposi-
tion to C3 of the ligand. This situation is the family 83 Newcastle
disease virus’ hemagglutinin neuraminidase in complex with 2,3-de-
hydro-2-deoxy-N-acetyl neuraminic acid.
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of clan-E (cfr. family 11 xylanases and their substrate’s ring-
C5-methylene group). Within the families 33 and 83, this is a
highly conserved isoleucine; the three families also possess in
its vicinity a highly conserved tyrosine. A typical situation
present in clan-E is the family 83 Newcastle disease virus’
hemagglutinin neuraminidase in complex with the inhibitor
2,3-dehydro-2-deoxy-N-acetyl neuraminic acid (PDB 1e8v)
[12], as shown in Fig. 7.
An interesting variant is the family 34 in£uenza A virus
(human strain, Tokyo/3/67) sialidase (Table 1) in complex
with sialic acid (PDB 2bat) [13]. Here, at the expected position
for isoleucine, a glutamate is found which is highly conserved
within this family. This residue has its K-methylene group
close to the ligand’s ring-C3-methylene function while its car-
boxyl group is pointing away.
4. General conclusion
As evidenced in the present comparative study, peculiarities
observed in the active site architecture at subsite 31 of glyco-
side hydrolases could be exploited for the design of potent
inhibitors (including compounds with medical importance)
and/or substrates of almost any of these enzymes.
In particular, the recognition of a hydrophobic platform
could lead to the presumption that carbohydrate analogues
lacking the C5-hydroxymethylene function and binding at
subsite 31 will behave as excellent inhibitors for many
D-hexapyranosyl glycoside hydrolases, except where a polar
interaction is expected (as with the metal-ion network of fam-
ily 2, or with the ‘top’ lysine of family 14 enzymes). Two
examples from our own experience are illustrative: (i) family
6 cellobiohydrolases recognise L-D-glucopyranosyl-L(1C4)-D-
xylopyranosides as excellent inhibitors [30,44] ; and (ii) the
recently synthesised 1K-methyl K(1C2)-D-lyxopyranosyl-D-
mannobioside is as yet the only known substrate-analogous
inhibitor spanning the essential subsites 31/+1 of family 38
and 47 K(1,2)-mannosidases, while the corresponding manno-
biose derivative is a substrate [45].
The strategical position of this hydrophobic platform au-
gurs well for the development of pyranoside-substrate ana-
logues where methyl or ethyl groups substitute for the C5-
hydroxymethylene group, which should readily be recognised
in subsite 31 by many of these enzymes (exceptions as above).
Such compounds are expected to act as good substrates, and
this is corroborated by recent literature reports where similar
relative preferences for L-D-glucosides, L-D-galactosides and
L-D-fucosides have been observed for family 1 L-glycosidases
from di¡erent organisms; e.g. comparison of the kinetic con-
stants of the Streptomyces sp. glucosidase for p-nitrophenyl
L-D-glucoside (Km 0.15 mM; kcat 28.4 s31), p-nitrophenyl L-D-
galactoside (4-OH axial ; Km 7.3 mM; kcat 118 s31) and
p-nitrophenyl L-D-fucoside (4-OH axial and 6-deoxy; Km
0.14 mM, kcat 37.1 s31) evidences the compensation of the
unfavourable interaction at C4 (D-galactose) through the in-
crease of hydrophobicity in the C6-deoxy derivative (D-fucose)
[46]. Derivatives of quinovosides (5-deoxy D-glucopyrano-
sides) should therefore be readily recognised as substrates by
many glucosidases except where the enzyme’s structural fea-
tures are contra-indicating. The preparation of these potential
substrates is underway.
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